Videos
AustinPx Live: Inside AustinPx: Live Company Overview
We kicked off our new AustinPx Live series with Inside AustinPx: Live Company Overview, featuring Chief Scientific Officer Dave Miller, Ph.D. In this 30-minute session, Dave walked attendees through our evolution from sponsor to CDMO, our integrated development and manufacturing capabilities, and how we apply science-backed, patient-focused strategies to solve complex formulation challenges including through our proprietary KinetiSol™ technology.
OutsourcedPharma Live: AustinPx Facility Tour & Capabilities Presentation
Join AustinPx's Chief Scientific Officer, Dave Miller, for a presentation focusing on our pharmaceutical manufacturing & development capabilities. Dave's presentation is followed by a virtual facility tour that will take you behind the scenes of our manufacturing areas by AustinPx's Senior VP, Operations, Justin Keen.
Overview: Kinetisol Technology from AustinPx
The KinetiSol™ Technology generates amorphous solid dispersions, dramatically improving the bioavailability of poorly soluble drugs. KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies - in a fraction of the time of other ASD technologies. With its significantly smaller ecological footprint, broader formulation design space, faster processing times and wider application to challenging molecules, KinetiSol is the next generation amorphous dispersion technology.
